Table 4.
Pathway Names | P values | FDR |
---|---|---|
PHOSPHORUS_OXYGEN_LYASE_ACTIVITY | 5.68E-08 | 0.000192 |
CYCLASE_ACTIVITY | 4.57E-08 | 0.000192 |
GNF2_PRDX2 | 2.16E-07 | 0.000487 |
MORF_RAP1A | 6.18E-07 | 0.001043 |
KUMAMOTO_RESPONSE_TO_NUTLIN_3A_UP | 1.87E-06 | 0.002526 |
MITOCHONDRION | 2.73E-06 | 0.003076 |
SHEDDEN_LUNG_CANCER_POOR_SURVIVAL _A6 |
3.48E-06 | 0.003357 |
VALK_AML_CLUSTER_2 | 5.04E-06 | 0.003783 |
GLUCOSE_CATABOLIC_PROCESS | 4.73E-06 | 0.003783 |
REACTOME_TRANSMISSION_ACROSS_CHEMI CAL_SYNAPSES |
6.68E-06 | 0.00435 |
BIOCARTA_CCR5_PATHWAY | 7.09E-06 | 0.00435 |
GRAHAM_CML_DIVIDING_VS_NORMAL_QUI ESCENT_UP |
1.09E-05 | 0.006114 |
MORF_BRCA1 | 1.35E-05 | 0.006995 |
MAP_KINASE_ACTIVITY | 3.16E-05 | 0.009928 |
REACTOME_NOREPINEPHRINE_NEUROTRAN SMITTER_RELEASE_CYCLE |
3.12E-05 | 0.009928 |
KCCGNSWTTT_UNKNOWN | 3.24E-05 | 0.009928 |
RESPONSE_TO_ENDOGENOUS_STIMULUS | 2.73E-05 | 0.009928 |
DELAYED_RECTIFIER_POTASSIUM_CHANNE L_ACTIVITY |
2.79E-05 | 0.009928 |
module_428 | 2.35E-05 | 0.009928 |
MORF_ATRX | 2.86E-05 | 0.009928 |
TAGCTTT,MIR-9 | 3.21E-05 | 0.009928 |
REACTOME_CLASS_C3_METABOTROPIC_GLU TAMATE_PHEROMONE_RECEPTORS |
2.80E-05 | 0.009928 |
RESPONSE_TO_DNA_DAMAGE_STIMULUS | 3.54E-05 | 0.010382 |
TOMLINS_PROSTATE_CANCER_UP | 4.63E-05 | 0.012494 |
MCCLUNG_DELTA_FOSB_TARGETS_2WK | 4.48E-05 | 0.012494 |
TRANSCRIPTION_COACTIVATOR_ACTIVITY | 5.68E-05 | 0.014751 |
RODRIGUES_NTN1_AND_DCC_TARGETS | 6.01E-05 | 0.015023 |
V$CREB_02 | 6.67E-05 | 0.016079 |
GCM_GSPT1 | 7.38E-05 | 0.017173 |
FERRARI_RESPONSE_TO_FENRETINIDE_DN | 8.00E-05 | 0.017994 |
ATAAGCT,MIR-21 | 8.47E-05 | 0.018436 |
NAKAMURA_CANCER_MICROENVIRONMENT _DN |
9.69E-05 | 0.020443 |
LEE_INTRATHYMIC_T_PROGENITOR | 0.00011 | 0.022509 |
TCCCCAC,MIR-491 | 0.000128 | 0.025452 |
CYTOSOLIC_PART | 0.000133 | 0.025637 |
WINTER_HYPOXIA_UP | 0.000169 | 0.029972 |
TRANSCRIPTION_ACTIVATOR_ACTIVITY | 0.000162 | 0.029972 |
MOREAUX_MULTIPLE_MYELOMA_BY_TACI_ UP |
0.000165 | 0.029972 |
NELSON_RESPONSE_TO_ANDROGEN_UP | 0.000179 | 0.030963 |
PATTERSON_DOCETAXEL_RESISTANCE | 0.000187 | 0.031433 |
MORF_PPP5C | 0.000191 | 0.031433 |
DNA_REPAIR | 0.000198 | 0.031826 |
V$NFY_Q6_01 | 0.000206 | 0.032314 |
XU_HGF_TARGETS_INDUCED_BY_AKT1_48H R_UP |
0.000218 | 0.033408 |
WATANABE_RECTAL_CANCER_RADIOTHER APY_RESPONSIVE_DN |
0.000245 | 0.035718 |
MORF_CCNF | 0.000241 | 0.035718 |
REGULATION_OF_LIPID_METABOLIC_PROCE SS |
0.000249 | 0.035718 |
WHITE_NEUROBLASTOMA_WITH_1P36.3_DEL ETION |
0.000258 | 0.036278 |
REGULATION_OF_SMALL_GTPASE_MEDIATE D_SIGNAL_TRANSDUCTION |
0.000338 | 0.043476 |
LAMELLIPODIUM | 0.000344 | 0.043476 |
REACTOME_GLUTAMATE_NEUROTRANSMIT TER_RELEASE_CYCLE |
0.000331 | 0.043476 |
TONKS_TARGETS_OF_RUNX1_RUNX1T1_FUSI ON_SUSTAINED_IN_GRANULOCYTE_UP |
0.000325 | 0.043476 |
V$IRF_Q6 | 0.000318 | 0.043476 |
V$CRX_Q4 | 0.000348 | 0.043476 |
PENG_LEUCINE_DEPRIVATION_UP | 0.000363 | 0.044551 |
chr6q24 | 0.000386 | 0.046488 |
INDUCTION_OF_APOPTOSIS_BY_INTRACELL ULAR_SIGNALS |
0.000409 | 0.048445 |
module_471 | 0.000425 | 0.049432 |
PUJANA_CHEK2_PCC_NETWORK | 0.000442 | 0.050452 |
V$CREB_Q4_01 | 0.00047 | 0.050452 |
PERINUCLEAR_REGION_OF_CYTOPLASM | 0.000486 | 0.050452 |
GAZDA_DIAMOND_BLACKFAN_ANEMIA_ER YTHROID_DN |
0.000471 | 0.050452 |
MATTIOLI_MULTIPLE_MYELOMA_WITH_14Q 32_TRANSLOCATIONS |
0.000482 | 0.050452 |
PROTEIN_HOMODIMERIZATION_ACTIVITY | 0.000464 | 0.050452 |
GRAHAM_CML_DIVIDING_VS_NORMAL_DIVI DING_DN |
0.000465 | 0.050452 |
LIU_TARGETS_OF_VMYB_VS_CMYB_UP | 0.000498 | 0.050942 |
REACTOME_IONOTROPIC_ACTIVITY_OF_KAI NATE_RECEPTORS |
0.000527 | 0.053129 |
PYEON_CANCER_HEAD_AND_NECK_VS_CER VICAL_DN |
0.000553 | 0.054085 |
ZHANG_PROLIFERATING_VS_QUIESCENT | 0.000548 | 0.054085 |
EXTERNAL_SIDE_OF_PLASMA_MEMBRANE | 0.000604 | 0.058227 |
GNF2_APEX1 | 0.00062 | 0.058953 |
ZUCCHI_METASTASIS_DN | 0.000638 | 0.059768 |
SNIJDERS_AMPLIFIED_IN_HEAD_AND_NECK_ TUMORS |
0.000651 | 0.060177 |
V$USF_C | 0.000708 | 0.062681 |
RNTCANNRNNYNATTW_UNKNOWN | 0.000689 | 0.062681 |
DEPHOSPHORYLATION | 0.000715 | 0.062681 |
chr5q34 | 0.000713 | 0.062681 |
RHEIN_ALL_GLUCOCORTICOID_THERAPY_D N |
0.000727 | 0.062882 |
CELLULAR_CARBOHYDRATE_CATABOLIC_P ROCESS |
0.000743 | 0.063492 |
REGULATION_OF_RAS_PROTEIN_SIGNAL_TR ANSDUCTION |
0.000757 | 0.06388 |
RICKMAN_HEAD_AND_NECK_CANCER_D | 0.000767 | 0.06388 |
module_441 | 0.00079 | 0.064239 |
REGULATION_OF_RAS_GTPASE_ACTIVITY | 0.000815 | 0.064239 |
CHIBA_RESPONSE_TO_TSA_UP | 0.000816 | 0.064239 |
SEIDEN_ONCOGENESIS_BY_MET | 0.000811 | 0.064239 |
MORI_MATURE_B_LYMPHOCYTE_DN | 0.000818 | 0.064239 |
ION_TRANSMEMBRANE_TRANSPORTER_ACT IVITY |
0.000836 | 0.064863 |
TIEN_INTESTINE_PROBIOTICS_24HR_UP | 0.000879 | 0.067459 |
SENGUPTA_NASOPHARYNGEAL_CARCINOM A_WITH_LMP1_UP |
0.000902 | 0.068386 |
REGULATION_OF_CATABOLIC_PROCESS | 0.000926 | 0.069418 |
TSAI_DNAJB4_TARGETS_DN | 0.000946 | 0.069432 |
DNA_DAMAGE_RESPONSESIGNAL_TRANSDU CTION_RESULTING_IN_INDUCTION_OF_APOP TOSIS |
0.000939 | 0.069432 |
KEGG_DRUG_METABOLISM_OTHER_ENZYM ES |
0.00099 | 0.070374 |
ENK_UV_RESPONSE_EPIDERMIS_UP | 0.000973 | 0.070374 |
NUCLEOBASENUCLEOSIDENUCLEOTIDE_AND_N UCLEIC_ACID_TRANSMEMBRANE_TRAN SPORTER_ACTIVITY |
0.000986 | 0.070374 |
KEGG_LIMONENE_AND_PINENE_DEGRADATI ON |
0.001016 | 0.07146 |
SAGIV_CD24_TARGETS_UP | 0.001083 | 0.075354 |
NUCLEOBASENUCLEOSIDENUCLEOTIDE_AN D_NUCLEIC_ACID_TRANSPORT |
0.001155 | 0.076817 |
JISON_SICKLE_CELL_DISEASE_UP | 0.001119 | 0.076817 |
module_528 | 0.001156 | 0.076817 |
ONDER_CDH1_TARGETS_1_UP | 0.001145 | 0.076817 |
TAKEDA_TARGETS_OF_NUP98_HOXA9_FUSI ON_16D_UP |
0.001161 | 0.076817 |
SARRIO_EPITHELIAL_MESENCHYMAL_TRAN SITION_UP |
0.001194 | 0.078262 |
chr6p | 0.001286 | 0.083098 |
ZIRN_TRETINOIN_RESPONSE_DN | 0.001293 | 0.083098 |
PACHER_TARGETS_OF_IGF1_AND_IGF2_UP | 0.001389 | 0.087629 |
PAPASPYRIDONOS_UNSTABLE_ATEROSCLER OTIC_PLAQUE_DN |
0.001384 | 0.087629 |
REACTOME_GLYCOGEN_BREAKDOWN_GLY COGENOLYSIS |
0.001428 | 0.089249 |
GGTAACC,MIR-409-5P | 0.001467 | 0.090596 |
EXTRACELLULAR_SPACE | 0.001476 | 0.090596 |
ZHAN_MULTIPLE_MYELOMA_CD2_DN | 0.001539 | 0.093601 |
REGULATION_OF_GTPASE_ACTIVITY | 0.00161 | 0.096446 |
REACTOME_ACTIVATION_OF_CHAPERONES_ BY_IRE1_ALPHA |
0.001615 | 0.096446 |
TGAGATT,MIR-216 | 0.001668 | 0.096635 |
OKUMURA_INFLAMMATORY_RESPONSE_LPS | 0.001654 | 0.096635 |
V$IRF1_Q6 | 0.001668 | 0.096635 |
MOOTHA_HUMAN_MITODB_6_2002 | 0.001675 | 0.096635 |
TGAYRTCA_V$ATF3_Q6 | 0.001731 | 0.098992 |
LOPES_METHYLATED_IN_COLON_CANCER_ UP |
0.0018 | 0.099652 |
BASSO_HAIRY_CELL_LEUKEMIA_DN | 0.001801 | 0.099652 |
HONRADO_BREAST_CANCER_BRCA1_VS_BR CA2 |
0.001772 | 0.099652 |
MORF_PSMF1 | 0.001769 | 0.099652 |